Literature DB >> 27498188

Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Jochen H Weishaupt1, Tony Hyman2, Ivan Dikic3.   

Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are age-related neurodegenerative diseases in which predominantly motor neurons and cerebral cortex neurons, respectively, are affected. Several novel ALS and FTD disease genes have been recently discovered, pointing toward a few overarching pathways in ALS/FTD pathogenesis. Nevertheless, a precise picture of how various cellular processes cause neuronal death, or how different routes leading to ALS and FTD are functionally connected is just emerging. Moreover, how the most recent milestone findings in the ALS/FTD field might lead to improved diagnosis and treatment is actively being explored. We highlight some of the most exciting recent topics in the field, which could potentially facilitate the identification of further links between the pathogenic ALS/FTD pathways related to autophagy, vesicle trafficking, and RNA metabolism.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  RNA granules; amyotrophic lateral sclerosis; autophagy; frontotemporal dementia; genetics

Mesh:

Substances:

Year:  2016        PMID: 27498188     DOI: 10.1016/j.molmed.2016.07.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  42 in total

Review 1.  Characteristics of circular RNAs generated by human Survival Motor Neuron genes.

Authors:  Eric W Ottesen; Ravindra N Singh
Journal:  Cell Signal       Date:  2020-06-15       Impact factor: 4.315

Review 2.  Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects.

Authors:  Sumeet Kumar; Navneesh Yadav; Sanjay Pandey; B K Thelma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

3.  Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.

Authors:  Emmanuelle C Genin; Sylvie Bannwarth; Françoise Lespinasse; Bernardo Ortega-Vila; Konstantina Fragaki; Kie Itoh; Elodie Villa; Sandra Lacas-Gervais; Manu Jokela; Mari Auranen; Emil Ylikallio; Alessandra Mauri-Crouzet; Henna Tyynismaa; Anna Vihola; Gaelle Augé; Charlotte Cochaud; Hiromi Sesaki; Jean-Ehrland Ricci; Bjarne Udd; Cristofol Vives-Bauza; Véronique Paquis-Flucklinger
Journal:  Neurobiol Dis       Date:  2018-08-06       Impact factor: 5.996

4.  Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.

Authors:  Jeffrey M Statland; Dan Moore; Yunxia Wang; Maureen Walsh; Tahseen Mozaffar; Lauren Elman; Sharon P Nations; Hiroshi Mitsumoto; J Americo Fernandes; David Saperstein; Ghazala Hayat; Laura Herbelin; Chafic Karam; Jonathan Katz; Heather M Wilkins; Abdulbaki Agbas; Russell H Swerdlow; Regina M Santella; Mazen M Dimachkie; Richard J Barohn
Journal:  Muscle Nerve       Date:  2018-11-26       Impact factor: 3.217

Review 5.  Building and decoding ubiquitin chains for mitophagy.

Authors:  J Wade Harper; Alban Ordureau; Jin-Mi Heo
Journal:  Nat Rev Mol Cell Biol       Date:  2018-01-23       Impact factor: 94.444

6.  TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.

Authors:  Jade-Emmanuelle Deshaies; Lulzim Shkreta; Alexander J Moszczynski; Hadjara Sidibé; Sabrina Semmler; Aurélien Fouillen; Estelle R Bennett; Uriya Bekenstein; Laurie Destroismaisons; Johanne Toutant; Quentin Delmotte; Kathryn Volkening; Stéphanie Stabile; Anaïs Aulas; Yousra Khalfallah; Hermona Soreq; Antonio Nanci; Michael J Strong; Benoit Chabot; Christine Vande Velde
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

7.  Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS.

Authors:  Anika M Helferich; Sarah J Brockmann; Jörg Reinders; Dhruva Deshpande; Karlheinz Holzmann; David Brenner; Peter M Andersen; Susanne Petri; Dietmar R Thal; Jens Michaelis; Markus Otto; Steffen Just; Albert C Ludolph; Karin M Danzer; Axel Freischmidt; Jochen H Weishaupt
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

Review 8.  Drug development in the era of precision medicine.

Authors:  Sarah A Dugger; Adam Platt; David B Goldstein
Journal:  Nat Rev Drug Discov       Date:  2017-12-08       Impact factor: 84.694

9.  Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS.

Authors:  Noam D Rudnick; Christopher J Griffey; Paolo Guarnieri; Valeria Gerbino; Xueyong Wang; Jason A Piersaint; Juan Carlos Tapia; Mark M Rich; Tom Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-13       Impact factor: 11.205

Review 10.  Traffic jam at the nuclear pore: All roads lead to nucleocytoplasmic transport defects in ALS/FTD.

Authors:  Claudia Fallini; Bilal Khalil; Courtney L Smith; Wilfried Rossoll
Journal:  Neurobiol Dis       Date:  2020-03-14       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.